Recent advances in the field of obesity treatment have presented a innovative candidate known as ALLUVI Retatrutide. This compound is a {highlyeffective GLP-1 receptor agonist, designed to amplify the effects of natural glucagon-like peptide-1. Retatrutide has shown significant efficacy in clinical trials, demonstrating significant reductions in bo